Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma

The metabolism of 5-fluorouracil (5-FU) is complex and the reason for the low response rate of tumor patients to 5-FU is currently unknown. The aim of this study was to evaluate whether spectral parameters obtained noninvasively by in vivo 19F nuclear magnetic resonance (NMR) spectroscopy can be use...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schlemmer, Heinz-Peter (VerfasserIn) , Bachert, Peter (VerfasserIn) , Semmler, Wolfhard (VerfasserIn) , Hohenberger, Peter (VerfasserIn) , Schlag, Peter M. (VerfasserIn) , Lorenz, Walter Josef (VerfasserIn) , Kaick, Gerhard van (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1994
In: Magnetic resonance imaging
Year: 1994, Jahrgang: 12, Heft: 3, Pages: 497-511
ISSN:1873-5894
DOI:10.1016/0730-725X(94)92544-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/0730-725X(94)92544-5
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/0730725X94925445
Volltext
Verfasserangaben:Heinz-Peter Schlemmer, Peter Bachert, Wolfhard Semmler, Peter Hohenberger, Peter Schlag, Walter J. Lorenz, Gerhard van Kaick

MARC

LEADER 00000caa a2200000 c 4500
001 1940126282
003 DE-627
005 20251105122530.0
007 cr uuu---uuuuu
008 251104s1994 xx |||||o 00| ||eng c
024 7 |a 10.1016/0730-725X(94)92544-5  |2 doi 
035 |a (DE-627)1940126282 
035 |a (DE-599)KXP1940126282 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schlemmer, Heinz-Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1025559967  |0 (DE-627)722927142  |0 (DE-576)17334805X  |4 aut 
245 1 0 |a Drug monitoring of 5-fluorouracil  |b in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma  |c Heinz-Peter Schlemmer, Peter Bachert, Wolfhard Semmler, Peter Hohenberger, Peter Schlag, Walter J. Lorenz, Gerhard van Kaick 
246 3 0 |a 19 F 
264 1 |c 1994 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist die Zahl "19" hochgestellt 
500 |a Elektronische Reproduktion der Druck-Ausgabe 19 April 2004 
500 |a Gesehen am 04.11.2025 
520 |a The metabolism of 5-fluorouracil (5-FU) is complex and the reason for the low response rate of tumor patients to 5-FU is currently unknown. The aim of this study was to evaluate whether spectral parameters obtained noninvasively by in vivo 19F nuclear magnetic resonance (NMR) spectroscopy can be used to assess individual response to 5-FU chemotherapy. Eighteen patients with metastases of colorectal carcinoma treated with 5-FU were examined by 19F NMR at 1.5 T. The NMR signal intensity versus time curves were observed for the cytostatic and its catabolite α-fluoro-β-alanine (FBAL). Clinical response to treatment was monitored by CTMR imaging of the liver and carcinoembryonic antigen (CEA) levels in the serum. 5-FU levels observed in IV-treated patients correlate with volumes of metastases in the liver region examined with the 19F NMR coil (k = 0.77, p < .0001). 5-FU levels in patients at their initial 5-FU chemotherapy were related with clinical response determined after three cycles of treatment. In the group of patients with extensive liver involvement and IV treatment, responders (n = 3) had enhanced 5-FU levels compared to nonresponders (n = 3). FBAL data indicate an apparent saturation of 5-FU catabolism in the liver for 5-FU doses > 1 g infused during 10 min. Mean absolute concentrations of FBAL were about 1 μmol per gram liver tissue. 19F NMR spectroscopy could be used to guide dose escalation schemes or to assess the modulation of 5-FU metabolism by other drugs in combined chemotherapy. 
650 4 |a 5-Fluorouracil 
650 4 |a Colorectal adenocarcinoma 
650 4 |a Drug monitoring 
650 4 |a In vivo F nuclear magnetic resonance spectroscopy 
650 4 |a Tumor response 
700 1 |a Bachert, Peter  |e VerfasserIn  |0 (DE-588)1103529633  |0 (DE-627)861285824  |0 (DE-576)251203298  |4 aut 
700 1 |a Semmler, Wolfhard  |d 1944-  |e VerfasserIn  |0 (DE-588)1037890477  |0 (DE-627)756409713  |0 (DE-576)391933639  |4 aut 
700 1 |a Hohenberger, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)1025311469  |0 (DE-627)72202875X  |0 (DE-576)370195574  |4 aut 
700 1 |a Schlag, Peter M.  |d 1948-2025  |e VerfasserIn  |0 (DE-588)115698965  |0 (DE-627)077414039  |0 (DE-576)170114910  |4 aut 
700 1 |a Lorenz, Walter Josef  |d 1932-  |e VerfasserIn  |0 (DE-588)1012794423  |0 (DE-627)699786398  |0 (DE-576)345947339  |4 aut 
700 1 |a Kaick, Gerhard van  |d 1935-  |e VerfasserIn  |0 (DE-588)1076637736  |0 (DE-627)835140083  |0 (DE-576)17826539X  |4 aut 
773 0 8 |i Enthalten in  |t Magnetic resonance imaging  |d Amsterdam [u.a.] : Elsevier Science, 1982  |g 12(1994), 3, Seite 497-511  |h Online-Ressource  |w (DE-627)306661160  |w (DE-600)1500646-3  |w (DE-576)081986750  |x 1873-5894  |7 nnas  |a Drug monitoring of 5-fluorouracil in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma 
773 1 8 |g volume:12  |g year:1994  |g number:3  |g pages:497-511  |g extent:15  |a Drug monitoring of 5-fluorouracil in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma 
856 4 0 |u https://doi.org/10.1016/0730-725X(94)92544-5  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/0730725X94925445  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251104 
994 |a 1994 
998 |g 1076637736  |a Kaick, Gerhard van  |m 1076637736:Kaick, Gerhard van  |d 50000  |e 50000PK1076637736  |k 0/50000/  |p 7  |y j 
998 |g 1012794423  |a Lorenz, Walter Josef  |m 1012794423:Lorenz, Walter Josef  |d 50000  |e 50000PL1012794423  |k 0/50000/  |p 6 
998 |g 115698965  |a Schlag, Peter M.  |m 115698965:Schlag, Peter M.  |d 50000  |e 50000PS115698965  |k 0/50000/  |p 5 
998 |g 1025311469  |a Hohenberger, Peter  |m 1025311469:Hohenberger, Peter  |p 4 
998 |g 1037890477  |a Semmler, Wolfhard  |m 1037890477:Semmler, Wolfhard  |d 50000  |e 50000PS1037890477  |k 0/50000/  |p 3 
998 |g 1103529633  |a Bachert, Peter  |m 1103529633:Bachert, Peter  |d 130000  |e 130000PB1103529633  |k 0/130000/  |p 2 
998 |g 1025559967  |a Schlemmer, Heinz-Peter  |m 1025559967:Schlemmer, Heinz-Peter  |d 50000  |e 50000PS1025559967  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1940126282  |e 4795959471 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"15 S."}],"relHost":[{"note":["Gesehen am 29.01.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Drug monitoring of 5-fluorouracil in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinomaMagnetic resonance imaging","recId":"306661160","language":["eng"],"pubHistory":["1.1982 -"],"part":{"extent":"15","volume":"12","text":"12(1994), 3, Seite 497-511","pages":"497-511","issue":"3","year":"1994"},"title":[{"title_sort":"Magnetic resonance imaging","subtitle":"an international journal of basic research and clinical applications","title":"Magnetic resonance imaging"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1982","publisher":"Elsevier Science","dateIssuedDisp":"1982-"}],"id":{"issn":["1873-5894"],"zdb":["1500646-3"],"eki":["306661160"]}}],"origin":[{"dateIssuedDisp":"1994","dateIssuedKey":"1994"}],"id":{"doi":["10.1016/0730-725X(94)92544-5"],"eki":["1940126282"]},"name":{"displayForm":["Heinz-Peter Schlemmer, Peter Bachert, Wolfhard Semmler, Peter Hohenberger, Peter Schlag, Walter J. Lorenz, Gerhard van Kaick"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Im Titel ist die Zahl \"19\" hochgestellt","Elektronische Reproduktion der Druck-Ausgabe 19 April 2004","Gesehen am 04.11.2025"],"language":["eng"],"recId":"1940126282","title":[{"subtitle":"in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma","title":"Drug monitoring of 5-fluorouracil","title_sort":"Drug monitoring of 5-fluorouracil"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Schlemmer, Heinz-Peter","given":"Heinz-Peter","family":"Schlemmer"},{"family":"Bachert","given":"Peter","roleDisplay":"VerfasserIn","display":"Bachert, Peter","role":"aut"},{"display":"Semmler, Wolfhard","roleDisplay":"VerfasserIn","role":"aut","family":"Semmler","given":"Wolfhard"},{"given":"Peter","family":"Hohenberger","role":"aut","display":"Hohenberger, Peter","roleDisplay":"VerfasserIn"},{"display":"Schlag, Peter M.","roleDisplay":"VerfasserIn","role":"aut","family":"Schlag","given":"Peter M."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Lorenz, Walter Josef","given":"Walter Josef","family":"Lorenz"},{"family":"Kaick","given":"Gerhard van","display":"Kaick, Gerhard van","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a SCHLEMMERHDRUGMONITO1994